PHARMACEUTICAL PREPARATIONS COMPOSITIONS

Brand Owner (click to sort) Address Description
ABCLICK AbTis Co., Ltd. #A-815, 142-10, Saneop-ro 156beon-gil, Gwonseon-gu, Suw Republic of Korea Pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of oncological, metabolic and ophthalmic diseases and disorders; lozenges for pharmaceutical purposes for the treatment of oncological, metabolic and ophthalmic diseases and disorders; cachets for pharmaceutical purposes for the treatment of oncological, metabolic and ophthalmic diseases and disorders; biotechnological preparations for medical purposes for the treatment of oncological, metabolic and ophthalmic diseases and disorders; reagents for medical use; drugs for medical purposes for the treatment of oncological, metabolic and ophthalmic diseases and disorders; antibodies for medical purposes for the treatment and diagnosis of oncological, metabolic and ophthalmic diseases and disorders; medicines for human purposes for the treatment of oncological, metabolic and ophthalmic diseases and disorders; anti-cancer preparations; chemically modified antibodies for the treatment and diagnosis of oncological, metabolic and ophthalmic diseases and disorders;
ABIREXA JANSSEN ONCOLOGY, INC. 10990 WILSHIRE BLVD. SUITE 1200 LOS ANGELES CA 90024 Pharmaceutical preparations and compositions for the treatment and/or prevention of cancer;
ABIRONE Cougar Biotechnology, Inc. 10990 Wilshire Blvd., Suite 1200 Los Angeles CA 90024 Pharmaceutical preparations and compositions for the treatment and/or prevention of cancer;The word ABIRONE has no meaning in a foreign language.;
ABIXA Cougar Biotechnology, Inc. 10990 Wilshire Blvd., Suite 1200 Los Angeles CA 90024 Pharmaceutical preparations and compositions for the treatment and/or prevention of cancer;The mark ABIXA has no meaning in a foreign language.;
ABRALTA JANSSEN ONCOLOGY, INC. 10990 WILSHIRE BLVD. SUITE 1200 LOS ANGELES CA 90024 Pharmaceutical preparations and compositions for the treatment and/or prevention of cancer;
BAVABOOST BAVARIAN NORDIC A/S Philip Heymans Alle 3 Hellerup DK-3490 Denmark Pharmaceutical preparations and compositions, including vaccines for prophylactic use and the treatment of infectious diseases, including Corona, COVID, and COVID19 viral diseases;
COUGIRA JANSSEN ONCOLOGY, INC. 10990 WILSHIRE BLVD. SUITE 1200 LOS ANGELES CA 90024 Pharmaceutical preparations and compositions for the treatment and/or prevention of cancer;The word COUGIRA has no meaning in a foreign language.;
ELASTASPHERE Elastagen Pty Ltd Australian Technology Park, Australia Pharmaceutical preparations and compositions for the treatment of acquired and congenital skin conditions, and acquired and congenital skin diseases; biochemical and biological substances for medical use, namely, elastin or elastin derivatives for the treatment of acquired and congenital skin conditions, and acquired and congenital skin diseases; biological substances for medical use, namely, drug delivery preparations for medical use, namely, forms of elastin used for the controlled release of pharmaceuticals; medical preparations, namely, skin care preparations;Biological products sold as components in cosmetics, namely, elastin preparations for cosmetics; cosmetics in the form of gels, foams, creams, lotions, milks and powders; cosmetic preparations; moisturizers;
ELASTATHERAPY Elastagen Pty Ltd Australian Technology Park, Australia Pharmaceutical preparations and compositions for the treatment of acquired and congenital skin conditions and acquired and congenital skin diseases; biochemical preparation for medical use in the nature of proteins and polysaccharide preparations for the treatment of acquired and congenital skin conditions and acquired and congenital skin diseases; pharmaceutical preparations, namely a drug delivery system comprising polymer-based oral tablets or tissue implants for the continuous release of a wide variety of therapeutic agents; medical preparations, namely medicated skin care preparations;Cosmetics in the nature of gels, foams, creams, lotions, milks and powders; cosmetic preparations; skin moisturizers;ELASTA THERAPY;
ELASTATHERAPY Elastagen Pty Ltd Australian Technology Park, Australia Pharmaceutical preparations and compositions for the treatment of acquired and congenital skin conditions and acquired and congenital skin diseases; biochemical and biological substances for medical use, namely, forms of protein and polysaccharide preparations for the treatment of acquired and congenital skin conditions and acquired and congenital skin diseases; drug delivery preparations for medical use, namely, forms of protein and polysaccharide preparations used for the controlled release of pharmaceuticals; medical preparations, namely, medicated skin care preparations;Cosmetics in the form of gels, foams, creams, lotions, milks and powders; cosmetic preparations; skin moisturizers;
HERTUGEN Celltrion, Inc. 23, Academy-ro, Yeonsu-gu Incheon 22014 Republic of Korea Pharmaceutical preparations and compositions for treatment of cancer;
HERTUMAB Celltrion, Inc. 23, Academy-ro, Yeonsu-gu Incheon 22014 Republic of Korea Pharmaceutical preparations and compositions for treatment of cancer;
JELMYTO UROGEN PHARMA LTD. 9 HaTa'asiya Street Ra'anana 4365007 Israel Pharmaceutical preparations and compositions for the treatment of urinary tract cancer;
MICENACLE NanoCarrier Co., Ltd. 144-15 Chuo, 226-39 Wakashiba Kashiwa, Chiba 277-0871 Japan Pharmaceutical preparations and compositions for the treatment and prevention of cancer;
MITOGEL UROGEN PHARMA LTD. 9 HaTa'asiya Street Ra'anana 4365007 Israel pharmaceutical preparations and compositions for the treatment of urinary tract cancer;
MITOGEL Theracoat Ltd. 13Ha Sadna Street Raanana 43650 Israel pharmaceutical preparations and compositions for the treatment of urinary tract cancer;
NAMCELNO NanoCarrier Co., Ltd. 144-15 Chuo, 226-39 Wakashiba Kashiwa, Chiba 277-0871 Japan Pharmaceutical preparations and compositions for the treatment and prevention of cancer;
NANOMYZE NanoCarrier Co., Ltd. 144-15 Chuo, 226-39 Wakashiba Kashiwa, Chiba 277-0871 Japan Pharmaceutical preparations and compositions for the treatment and prevention of cancer;
POSJELTY UROGEN PHARMA LTD. 9 HaTa'asiya Street Ra'anana 4365007 Israel pharmaceutical preparations and compositions for the treatment of bladder cancer;
VIDKAPSI BAVARIAN NORDIC A/S Philip Heymans Alle 3 Hellerup DK-3490 Denmark Pharmaceutical preparations and compositions, including vaccines for prophylactic use and the treatment of infectious diseases, including Corona, COVID, and COVID19 viruses' diseases;
XCELLERATED Xcyte Therapies, Inc. 1124 Columbia Street, Suite 130 Seattle WA 98104 Pharmaceutical preparations and compositions for therapeutic use, namely, for expanding, selecting and deleting cells of the immune systems; preparations and compositions for therapeutic use, namely, for activating cells of the immune systems; pharmaceutical preparations for use in the treatment of cancer, infectious diseases and immunodeficiencies; antibody-conjugated beads, antibody-conjugated micro-beads and antibody-conjugated microspheres for promoting a therapeutic effect on the body;
XCELLERATED Dynal Biotech AS PO Box 114 Smestad N-0309 Oslo Norway Pharmaceutical preparations and compositions for therapeutic use, namely, for expanding, selecting and deleting cells of the immune systems; pharmaceutical preparations and compositions for therapeutic use, namely, for activating cells of the immune systems; pharmaceutical preparations for use in the treatment of cancer, infectious diseases and immune deficiencies; namely, antibody-conjugated beads, antibody-conjugated micro-beads and antibody-conjugated microspheres, for promoting a therapeutic effect on the body, namely, by enhancing the immune system;
ZUSDURI UROGEN PHARMA LTD. 9 HaTa'asiya Street Ra'anana 4365007 Israel pharmaceutical preparations and compositions for the treatment of bladder cancer;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.